First-Line Zongertinib in Advanced HER2-Mutant Non–Small-Cell Lung Cancer

Original Article

J.V. Heymach, N. Yamamoto, N. Girard, G. Ruiter, E.F. Smit, D. Planchard, E. Nadal, Y.-L. Wu, J. Zugazagoitia, H.-Y. Tu, C.S. Baik, K. Yoh, R.A. Soo, Y. Zhao, J.K. Sabari, M. Wermke, M. Scheffler, M.-J. Ahn, K. Fernamberg, L. Schroeter, B. Sadrolhefazi, C. Thamer, S. Eigenbrod-Giese, and S. Popat

N Engl J Med 2026;394:1675-1684

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
04/29/2026
Course expires: 
04/30/2028

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Please sign in or create an account to take the course.